Trial intelligence / Profile preview

PRP in Temporomandibular Disorders

NCT03371888Phase 3Completed

Sponsor
Medical University of Silesia
Start
Dec 2017
Primary completion
Dec 2018
Modality
Adoptive Cell Transfer
Countries
1
01

Overview

A Phase 3 trial of platelet-rich plasma injection in temporomandibular disorders (TMD), sponsored by Medical University of Silesia. Started Dec 2017; status: completed.

02

Drugs

platelet-rich plasma injection
03

Conditions

temporomandibular disorders (TMD)

Beyond the preview

Go deeper on NCT03371888.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03371888.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call